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background:  It has been a challenge to develop a method to accurately measure QT interval in patients (pts.) with atrial fibrillation (AF) 
especially those on Dofetilide protocol who have the risk of QT prolongation, and hence fatal arrhythmias such as torsades. We sought 
to compare QTc measurements using 4 methods, Bazett formula using longest QT (QTcL) and average of 3 QT intervals (QTcA) and 
Fridericia formula using both. The purpose of this study was to determine if there is any added benefit of measuring QTcA over QTcL.
Methods:  A retrospective analysis of EKGs was done for 451 pts. treated for AF with Dofetilide protocol. Pts. with paced rhythms, those 
without EKG in AF at Dofetilide initiation, and those who failed to convert to sinus rhythm (SR) were excluded. A single blinded observer 
using a 0.5-minute scale precision ruler studied the QT intervals of 658 EKGs of the remaining 174 patients.
results:  There was a significant difference in the QTc values obtained using QTcL vs. QTcA by Bazett formula (452.14 ± 3.59 vs. 436.43 
± 4.59; p <0.0001) and Fridericia formula (434.25 ± 3.45 vs. 419.33 ± 4.53; p<0.0001) for all EKGs. However, there was no statistical 
difference in dose changes done according to standard protocol using QTcL v/s QTcA for either Bazett (p =0.71) or Fridericia method 
(p=0.66). To compare the different methods, we studied the correlation of the QTc of last EKG in AF to the first EKG in SR. The Pearson 
correlation coefficient for AF with SR using QTcL & Bazett was 0.729 (p<0.01). Correlation for the EKG in AF and SR for QTcA using 
Bazett was 0.758 (p<0.01). Using Friderica, QTcL in AF showed a positive correlation with SR, coefficient 0.793 (p <0.01). Using QTcA with 
Fridericia, the coefficient value was 0.81 (p<0.01).
Conclusion:  Across all four methods there was a significant statistical difference between the values obtained by QTcL vs. QTcA. 
However, our results suggest that there is no benefit in measuring QTcA over QTcL in deciding Dofetilide dose changes. Although QTcA 
using Fridericia method appears to be the most positively correlated to SR, there is no clinical benefit in using it over QTcL in patients with 
AF on Dofetilide protocol.
